Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EvaLuate EndoVascular Treatment of Acutely Ruptured Shallow Intradural Aneurysms With the Pipeline™ Flex Embolization Device With Shield TEchnology™ (ELEVATE)

NCT04391803 is registered in ClinicalTrials.gov with Medtronic Neurovascular Clinical Affairs as lead sponsor.

NCT NCT04391803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04391803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EvaLuate EndoVascular Treatment of Acutely Ruptured Shallow Intradural Aneurysms With the Pipeline™ Flex Embolization Device With Shield TEchnology™ (ELEVATE)
Lead sponsor
Medtronic Neurovascular Clinical Affairs
Phase
Not applicable
Overall status
Terminated
Start date
May 6, 2022
Completion date
October 20, 2025
Enrollment
25 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

intracranial aneurysm, ruptured aneurysm